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Abstract
Breast and cervical cancer have had disparate impact on the lives of women. The burden of breast 
and cervical cancer is more prominent among some racial and ethnic minority women. Providing 
comprehensive care to all medically underserved women is a critical element in continuing the 
battle to reduce cancer burden and eliminate disparities. The National Breast and Cervical Cancer 
Early Detection Program is the only nationally organized cancer screening program for 
underserved women in the United States. Its public health goal is to ensure access to high-quality 
screening, follow-up, and treatment services for diverse and vulnerable populations that, in turn, 
may reduce disparities.
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INTRODUCTION
Breast and cervical cancer have had significant impact on the lives of many women. 
Although there has been progress to reduce the burden of breast and cervical cancer, this 
progress has not had the same benefit in all populations.1 The burden of breast and cervical 
cancer is more prominent among some racial and ethnic minority women. For example, 
Hispanic women have the highest rate of developing cervical cancer compared with all other 
groups, whereas black women die at a much higher rate from both breast cancer and cervical 
cancer.2 The reason for this disparity is more than just screening: it is multifocal.3–5 
Therefore, providing a comprehensive approach to care is a critical element in continuing 
the battle to reduce cancer burden and eliminate disparities.
There is clear evidence that screening tests such as mammography and Papanicolaou (Pap) 
tests have some limitations, 6,7 and several recent articles have questioned the value of 
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routine screening for breast cancer.6,8,9 However, randomized controlled trials have 
demonstrated that breast cancer screening decreases mortality. In addition, screening is 
particularly important among populations who are at high risk or are rarely/never 
screened.10–13 Research has demonstrated that racial/ethnic minorities and those from lower 
socioeconomic backgrounds are less likely to have regular screening and more likely to be 
diagnosed with late-stage disease.14–16 It is important to expand the current debate about the 
effectiveness of mammography to include the important continued role of screening in 
helping address these disparities.
Reaching medically underserved women is a start to reducing disparities in breast and 
cervical cancer mortality. Over the past 20 years, the Centers for Disease Control and 
Prevention (CDC) has worked to decrease these disparities with its National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP) through cooperative agreements 
with states, tribes, and territories to provide access to breast and cervical cancer screening, 
diagnostic tests, and treatment referral services to low-income women who would not 
otherwise have access to these services. Reducing morbidity and mortality from breast and 
cervical cancer goes beyond screening. It is well documented that many women do not 
receive needed followup or treatment services.17,18 Women with abnormal screening results 
need timely, appropriate, and high-quality followup; and those diagnosed with cancer need 
timely, appropriate, and high-quality treatment. The success of the NBCCEDP in developing 
a useful approach to quality assurance for diagnostic evaluation and treatment initiation19,20 
can serve as a model for health care systems across the United States.
To truly reduce breast and cervical cancer morbidity and mortality, cancer care needs to be a 
comprehensive program that provides a continuum of care. The needs of all groups of 
women must be clearly defined to ensure that they get the care they need. Often, this care is 
individualized and opportunistic when women access the health care system. The benefits of 
screening are maximized when appropriate follow-up is done. Having an organized system 
that incorporates evidence-based interventions may help all women get access to high-
quality care. The NBCCEDP has provided such an organized and comprehensive approach 
to breast and cervical cancer screening. It is the only national example of such an approach. 
Below, we describe the specific program components beyond screening used to target the 
undeserved population who would not otherwise have access to screening services.2
Public Education and Outreach
The NBCCEDP uses public education and outreach to increase the number of women who 
receive breast and cervical cancer screenings. Although the initial goal is to link the public 
health program to the community it serves, public education and outreach expand beyond 
the women served by the NBCCEDP. The grantees use population-based strategies to 
address individual, organizational, and environmental level factors that have an impact on 
screening and follow-up behavior and choices. The overall focus is to increase awareness, 
address barriers, and motivate all women to get appropriate screenings and improve health 
behaviors.
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Quality Assurance/Quality Improvement
The NBCCEDP uses quality-assurance and quality-improvement processes to ensure that all 
women receive high-quality and appropriate screening services. The CDC has developed a 
set of quality indicators by which the delivery of services is measured. Clinical and service 
delivery data are collected and compared with predetermined performance benchmarks. 
When indicated, steps are put into place to help providers meet acceptable quality standards. 
By using quality-assurance processes, the NBCCEDP grantees can maximize the quality of 
patient screening, diagnostic services, and follow-up care.
Case Management and Patient Navigation
The NBCCEDP provides case management and patient navigation services to assist women 
in obtaining needed services. All grantees maintain a network of providers and partnerships 
with health care delivery organizations to facilitate timely access to screening and diagnostic 
services. Both case management and patient navigation help women overcome barriers to 
services so that follow-up, treatment referral, and treatment initiation are obtained without 
excessive delays. This assistance includes helping women get screening appointments, 
understand their screening results, undergo appropriate diagnostic testing, and receive 
referrals for treatment services, if needed.
Professional Development
Professional development activities are implemented to improve clinical outcomes. The 
NBCCEDP provides professional development to ensure that participating providers are 
current on evidence-based clinical standards regarding breast and cervical cancer screening 
and diagnosis and are following women who have abnormal screening results. Focus of the 
program has been on the use of evidence-based interventions to increase breast and cervical 
cancer screening and to develop the capacity to deliver education and training to program 
providers. This helps grantees improve clinical practice outcomes and increase screening 
rates.
Data Management and Evaluation
Grantees provide biennial reports of patient demographics and clinical data to the CDC. The 
data go through a rigorous process of submission, quality checks, and feedback reporting. 
The CDC and the grantees use these data for quality assurance and quality improvement, 
program evaluation, and program policy development. Data are an integral part of the 
CDC’s performance management system to ensure high-quality services. This data 
management and evaluation process can be a useful model for other clinical service delivery 
programs.
Partnerships
To ensure the delivery of quality screening and diagnostic services to those who need them, 
the NBCCEDP maintains key partnerships at both the national and local levels. These 
partners have been instrumental in the success of this program. For instance, working with 
health care systems, community-based organizations, religious groups, and coalitions 
expands the reach of the program to identify those hard-to-reach women who may be most 
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at risk. Furthermore, these partnerships have enhanced awareness among women, informed 
policies, provided professional development, and supported screening activities. Whether 
educating, motivating, or helping to reduce structural barriers, partnerships have influenced 
the effectiveness of the program to serve its target population.
The NBCCEDP is the only nationally organized cancer screening program for underserved 
women in the United States. Public health is well equipped to ensure access to high-quality 
screening, follow-up, and treatment services for diverse and vulnerable populations that, in 
turn, may reduce disparities. This supplement of Cancer contains a series of articles that 
describes the comprehensive, multifocal approach of the NBCCEDP for providing breast 
and cervical cancer screening and diagnostic services. This is the first time that details on 
the individual program components have been published, including state examples of 
successful component interventions.
Acknowledgments
FUNDING SUPPORT
This Supplement edition of Cancer has been sponsored by the US Centers for Disease Control and Prevention 
(CDC), an Agency of the Department of Health and Human Services, under the Contract #200-2012-M-52408 
00002.
REFERENCES
1. Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975–
2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV 
vaccination coverage levels. J Natl Cancer Inst. 2013; 105:175–201. [PubMed: 23297039] 
2. US Department of Health and Human Services, Centers for Disease Control and Prevention, and 
National Cancer Institute; US Cancer Statistics Working Group. [Accessed October 10, 2013] 
United States Cancer Statistics: 1999–2009 Incidence and Mortality Web-Based Report. Available 
at: http://apps.nccd.cdc.gov/uscs/index.aspx
3. Centers for Disease Control and Prevention. Vital signs: racial disparities in breast cancer severity—
United States, 2005–2009. MMWR Morb Mortal Wkly Rep. 2012; 61:922–926. [PubMed: 
23151952] 
4. Silber JH, Rosenbaum PR, Clark AS, et al. Characteristics associated with differences in survival 
among black and white women with breast cancer. JAMA. 2013; 310:389–397. [PubMed: 
23917289] 
5. Downs LS, Smith JS, Scarinci I, Flowers L, Parham G. The disparity of cervical cancer in diverse 
populations. Gynecol Oncol. 2008; 109(2 suppl.):S22–S30. [PubMed: 18482555] 
6. Bleyer A, Welch HG. Effect of 3 decades of screening mammography on breast-cancer incidence. N 
Engl J Med. 2012; 367:1998–2005. [PubMed: 23171096] 
7. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for 
Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening 
guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012; 
62:147–172. [PubMed: 22422631] 
8. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. 
JAMA. 2009; 302:1685–1692. [PubMed: 19843904] 
9. Miller AB. Overdiagnosis of breast cancer. Int J Cancer. 2013; 133:2511–2511. [PubMed: 
23716268] 
10. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the US Preventive 
Services Task Force. Ann Intern Med. 2009; 151:727–737. [PubMed: 19920273] 
Miller et al. Page 4
Cancer. Author manuscript; available in PMC 2015 August 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
11. Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 131: screening for 
cervical cancer. Obstet Gynecol. 2012; 120:1222–1238. [PubMed: 23090560] 
12. Schopper D, Wolf C. How effective are breast cancer screening programmes by mammography? 
Review of the current evidence. Eur J Cancer. 2009; 45:1916–1923. [PubMed: 19398327] 
13. Cancer Research UK, Independent UK Panel on Breast Cancer Screening. The Benefits and Harms 
of Breast Cancer Screening: An Independent Review. 2012. Available at: http://
www.cancerresearchuk.org/prod_consump/groups/cr_common/@nre/@hea/documents/
generalcontent/ibsr-fullreport.pdf. 
14. Taplin SH, Ichikawa L, Yood MU, et al. Reason for late-stage breast cancer: absence of screening 
or detection, or breakdown in followup? J Natl Cancer Inst. 2004; 96:1518–1527. [PubMed: 
15494602] 
15. Grabler P, Dupuy D, Rai J, Bernstein S, Ansell D. Regular screening mammography before the 
diagnosis of breast cancer reduces black:- white breast cancer differences and modifies negative 
biological prognostic factors. Breast Cancer Res Treat. 2012; 135:549–553. [PubMed: 22886477] 
16. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography 
explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006; 144:541–553. 
[PubMed: 16618951] 
17. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl 
Cancer Inst. 2002; 94:334–357. [PubMed: 11880473] 
18. Fiscella K, Humiston S, Hendren S, et al. Eliminating disparities in cancer screening and follow-up 
of abnormal results: what will it take? J Health Care Poor Underserved. 2011; 22:83–100. 
[PubMed: 21317508] 
19. Richardson LC, Royalty J, Howe W, Helsel W, Kammerer W, Benard VB. Timeliness of breast 
cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early 
Detection Program, 1996–2005. Am J Public Health. 2010; 100:1769–1776. [PubMed: 20019308] 
20. Benard VB, Howe W, Royalty J, Helsel W, Kammerer W, Richardson LC. Timeliness of cervical 
cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early 
Detection Program. J Womens Health (Larchmt). 2012; 21:776–782. [PubMed: 22506920] 
21. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP). [Accessed 
October 16, 2013] The NBCCEDP Conceptual Framework. Available at: http://www.cdc.gov/
cancer/nbccedp/concept.htm
Miller et al. Page 5
Cancer. Author manuscript; available in PMC 2015 August 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
